NEW YORK (GenomeWeb News) – A day after Luminex’s respiratory viral panel got the nod from the US Food and Drug Administration, the company signed up ViraCor Laboratories as the first national reference lab to offer the test, ViraCor said today.
As GenomeWeb Daily News reported Thursday, Luminex’s xTAG RVP detects 12 major respiratory viruses and subtypes from one sample, including adenovirus, three strains of influenza A, rhinovirus, and others.
The panel’s sensitivity and specificity “helps eliminate incorrect diagnosis by greatly reducing false negative results that are common with conventional testing methods,” said ViraCor VP and CSO Steve Kleiboeker.
Viacor noted that it offers a 24-hour turnaround time on tests.
Financial terms of the agreement were not released.